Niaura Raymond, Abrams David B
Centers for Behavioral and Preventive Medicine, Brown Medical School, the Miriam Hospital, Providence, Rhode Island 02903, USA.
J Consult Clin Psychol. 2002 Jun;70(3):494-509. doi: 10.1037//0022-006x.70.3.494.
The authors review developments in understanding smoking cessation interventions over the past decade. Noteworthy is the unprecedented growth of research and knowledge that has left a deeper understanding of how best to use new and existing behavioral and pharmacologic tools and strategies to help smokers quit. The status of public-health-level interventions is evaluated, questions are raised concerning their efficacy, and suggestions are offered for further refinement of these intervention strategies. Development of cessation guidelines is reviewed, and the state of knowledge concerning behavioral and pharmacologic interventions is summarized. The authors also present agendas for behavioral and pharmacologic research related to smoking cessation and discuss individual difference factors among smokers that may prove to be important in designing new and refining existing treatments.
作者回顾了过去十年中在理解戒烟干预措施方面的进展。值得注意的是,研究和知识出现了前所未有的增长,这使人们对如何最好地利用新的和现有的行为及药物工具与策略来帮助吸烟者戒烟有了更深入的理解。对公共卫生层面干预措施的现状进行了评估,对其有效性提出了疑问,并为进一步完善这些干预策略提供了建议。回顾了戒烟指南的制定情况,并总结了行为和药物干预方面的知识现状。作者还提出了与戒烟相关的行为和药物研究议程,并讨论了吸烟者之间的个体差异因素,这些因素在设计新的治疗方法和完善现有治疗方法时可能被证明是重要的。